CRA is a proud sponsor of the event.
Josh Sherman is a panelist during the session titled “Global antitrust trends reshaping the life sciences market” discussing:
- How tariffs and trade policy are impacting pharmaceutical supply chains and investment strategies
- China’s rise as a biotech innovation and licensing powerhouse
- The latest enforcement developments from European regulators, and how their proposed merger guidelines may impact deals in the US
For more information on this event, click here.
